The National Pharmaceutical Council (NPC) says the Food and Drug Administration's (FDA) recent real-world evidence framework is a step in the right direction. The FDA released the framework Thursday, Dec. 6, and lays out how the federal agency will assess potential uses for RWE in drug […]
Latest Stories
Walgreens, FedEx Partner for Next-Day Prescription Deliveries
In a bid to compete with drug delivery initiatives deployed by Amazon and CVS Health's CarePass, Walgreens and FedEx have partnered to offer next-day delivery across the country. According to a Forbes report, Walgreens touted the new relationship as the "fastest choice for next-day prescription […]
FDA to Use 3-Step Approach in RWE Initiative
The Food and Drug Administration in a new framework says it will use a three-step approach to determining how to best use real-world evidence in drug approvals. According to a RAPS.org report, the agency says it will consider the following:Whether the real-world data are fit for use; Whether […]
New CVS Offering to Compete with Amazon
CVS Health's recent launch of CarePass, a new membership program which offers delivery benefits, discounts and in-store credit, is poised to rival tech giant Amazon's offerings. According to a Managed Healthcare Executive report, CarePass will offer members of the program, which costs $5 per month […]
FDA Creating Roadmap for RWE Integration
The U.S. Food and Drug Administration (FDA) is working to develop a roadmap for the implementation of real-world evidence (RWE) into the drug development arena, and as part of that effort released a framework for assessing its potential uses. According to a BioCentury report, the framework makes […]
Forbes Summit Spurs Robust Talks on Drug Prices, Innovation in Pharma
The 7th annual Forbes Healthcare Summit brought a dynamic conversation about the state of pharmaceuticals, drug pricing and innovation, BioSpace reports. Vertex Pharmaceuticals' Jeffrey Leiden said it's imperative that companies consider the entire "$3 trillion system" and search for important […]
White Paper Spotlights RWD, RWE
A new white paper from FirstWord explores current real-world data and real-world evidence practices in the health care industry, as well as challenges yet to be conquered. The report, "Charting Real World Data and Evidence - Activity and Capabilities," includes input from 100 U.S. and European […]
Aetna, Ascension Join Blockchain Initiative Synaptic Health Alliance
Aetna and Ascension recently announced plans to join the Synaptic Health Alliance, a health care initiative aimed at exploring ways blockchain technology could help tackle provider data issues, according to a Healthcare Informatics report. The roster involved in the effort now consists of Aetna, […]
Survey: Payers Say Customer Experience, Data, Growth Top Priorities for 2019
A new survey conducted by North Highland, a global consulting firm, found more than 80 percent of large payers are looking to focus on customer experience, data and analytics and organic growth in 2019, FierceHealthcare reports. According to the report, only slightly more than a quarter of the 100 […]
Johnson & Johnson CEO Supports Limited Change in Pricing
Johnson & Johnson CEO Alex Gorsky says he's receptive to change in how drugs are priced, but added that breakthrough drugs justify high prices. "Obviously you've got to work with payers, providers," Gorsky tells Fortune. "You've got to work with the government to make sure that's done in a […]
